References
- Sughrue ME, Yang I, Kane AJ, Fang S, Clark AJ, Aranda D, . Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol 2011; 101:463–76.
- Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D, . Craniopharyngioma: A comparison of tumor control with various treatment strategies. Neurosurg Focus 2010;28:E5.
- Rajan B, Ashley S, Gorman C, Jose CC, Horwich A, Bloom HJ, . Craniopharyngioma – a long-term results following limited surgery and radiotherapy. Radiother Oncol 1993;26:1–10.
- Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, . Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 2007;82:90–5.
- Regine WF, Mohiuddin M, Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 1993; 27:13–21.
- Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 2002;54:1114–20.
- Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, . Craniopharyngiomas in children and adults: Systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005;62:397–409.
- Pemberton LS, Dougal M, Magee B, Gattamaneni HR. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol 2005;77:99–104.
- Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Neurosurg Focus 1997;3:e1.
- Jose CC, Rajan B, Ashley S, Marsh H, Brada M. Radiotherapy for the treatment of recurrent craniopharyngioma. Clin Oncol (R Coll Radiol) 1992;4:287–9.
- Rodriguez FJ, Scheithauer BW, Tsunoda S, Kovacs K, Vidal S, Piepgras DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol 2007;31:1020–8.
- Kawamata T, Amano K, Aihara Y, Kubo O, Hori T. Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities. Neurosurg Rev 2010;33:71–81.
- Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, . High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 2005;62:197–204.